South Korea’s Financial Regulator Sanctions KB Life Executive Over AML System Lapses

COMPANY / Reporter Paul Lee / 2026-03-03 00:53:12

Photo courtesy of Yonhap News

 

 

[Alpha Biz= Paul Lee] South Korea’s Financial Supervisory Service has imposed a regulatory sanction equivalent to a warning on a KB Life Insurance executive, who served as the company’s compliance officer, for improperly operating the firm’s anti-money laundering systems, according to financial industry sources on Feb. 28.

The sanction was issued in the form of a notice of regulatory violations applicable to a former executive.

According to the FSS, KB Life had established procedures to assess the risk of money laundering and other illicit financial activities as part of its customer due diligence process, but failed to operate the system appropriately and did not conduct sufficient monitoring.

As a result, the insurer did not carry out proper risk assessments for a significant number of customers, leading to the failure to identify dozens of high-risk clients.

Under South Korea’s Act on Reporting and Use of Specified Financial Transaction Information, financial institutions are required to establish and properly operate procedures and internal guidelines to assess money laundering risks.

The regulator also found that KB Life failed to obtain additional information—such as the purpose of transactions and the source of funds—when conducting insurance policy loan transactions with high-risk customers, including foreign nationals.

The law requires financial institutions to verify transaction purposes and sources of funds when there is a risk that a customer may be involved in money laundering.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

Seized Cryptocurrency Linked to National Tax Service Stolen Twice, Police Launch Formal Probe
Presidential Office Says It Is Closely Monitoring Situation Following Reported Death of Iran’s Supreme Leader
Korea Tax Authority Accidentally Exposes Crypto Wallet Recovery Phrase, Assets Potentially Stolen
Court Orders Provisional Seizure of Assets at Dawonsys Amid Dispute with Korail
Samchundang Pharm Signs Exclusive License and Commercialization Deal for Oral GLP-1 in 11 European Countries
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS